NEW WHITE PAPER:  Solving Atypical Protein Expression with Transposase Technology    Dive in today!
Contact Us
Contact Us

AGC Biologics

New leadership roles to drive operational readiness and regional growth for the company in Japan

1 min read

AGC Biologics Announces Leadership Updates Amid Groundbreaking of New Yokohama Site

December 22, 2024 at 6:00 PM
Press Release Business Updates
Read press release
AGC Biologics CMC Jumpstart™ Program Offers Platform Assessments

2 min read

New AGC Biologics CMC Jumpstart™ Program Offers CGT Developers Viral Vector Platform Assessments that Control Costs and Analyze Feasibility

December 18, 2024 at 9:15 AM
Cell & Gene Therapy Press Release
Read press release
Autolus and AGC Biologics

2 min read

AGC Biologics to Manufacture LVV for CAR-T Therapy Approved by FDA for Autolus Therapeutics’ AUCATZYL®

December 11, 2024 at 9:00 AM
Cell & Gene Therapy Press Release
Read press release

2 min read

AGC Biologics Appoints Alberto Santagostino as new Chief Executive Officer

October 28, 2024 at 3:00 AM
Press Release Business Updates
Read press release
Seattle BLAs - 3 approvals in 2024

1 min read

AGC Biologics Seattle Achieves Approval for all 2024 Biologics License Applications from U.S. Food and Drug Administration, Concluding Pre-License Inspection

October 17, 2024 at 3:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
AGC Biologics Begins Operations at New State-of-the-Art Manufacturing Building in Copenhagen after Successful Inspection and Licensing from Danish Medicines Agency

1 min read

AGC Biologics Begins Operations at New State-of-the-Art Manufacturing Building in Copenhagen after Successful Inspection and Licensing from Danish Medicines Agency

October 9, 2024 at 11:00 PM
Mammalian & mAbs Press Release Business Updates
Read press release
CompleCure and AGC Biologics Chiba Project Announcement

2 min read

CompleCure Partners with AGC Biologics’ Chiba Site to Develop Advanced Anti-Cancer Therapeutic Using Pioneering AMDC Technology

September 23, 2024 at 4:45 AM
Press Release Process Development Microbial
Read press release

1 min read

AGC and MEDINET Strategic Partnership to Accelerate CGT CDMO Business in Japan

September 16, 2024 at 5:04 PM
Cell & Gene Therapy Press Release
Read press release

2 min read

AGC Biologics Completes PPQ Manufacturing with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab

August 25, 2020 at 7:00 AM
Press Release
Read press release

1 min read

AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage

August 13, 2020 at 6:00 AM
Press Release
Read press release
Prev 1 2 3 4 5 Next